868696-43-9 Usage
Chemical family
Oxadiazole
The compound belongs to the oxadiazole family, which is a group of heterocyclic compounds containing an oxadiazole ring.
Structural feature
Oxadiazole ring with an attached amine group
The compound is characterized by the presence of an oxadiazole ring fused with an amine group, which contributes to its chemical properties and reactivity.
Applications
Organic synthesis and pharmaceutical research
The compound is used in the synthesis of various organic compounds and is also studied in the context of pharmaceutical research.
Potential applications
Development of new drugs and pharmaceuticals
Due to its structural and chemical properties, the compound has potential applications in the development of new drugs and pharmaceuticals.
Biological activities
Derivatives and analogs exhibit various biological activities
Studies have shown that derivatives and analogs of the compound exhibit a range of biological activities, making it an interesting compound for further investigation and potential drug discovery.
CAS Registry Number
9CI
The compound is registered with the Chemical Abstracts Service (CAS) under the number 9CI, which is a unique identifier used to search for chemical compounds in databases.
Check Digit Verification of cas no
The CAS Registry Mumber 868696-43-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,8,6,9 and 6 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 868696-43:
(8*8)+(7*6)+(6*8)+(5*6)+(4*9)+(3*6)+(2*4)+(1*3)=249
249 % 10 = 9
So 868696-43-9 is a valid CAS Registry Number.
868696-43-9Relevant articles and documents
9H-Xanthene-9-carboxylic acid [1,2,4]oxadiazol-3-yl- and (2H-tetrazol-5-yl)-amides as potent, orally available mGlu1 receptor enhancers
Vieira, Eric,Huwyler, Joerg,Jolidon, Synese,Knoflach, Frederic,Mutel, Vincent,Wichmann, Juergen
, p. 4628 - 4631 (2007/10/03)
Small molecule mGluR1 enhancers based on the lead compound (9H-xanthene-9-carbonyl)-carbamic acid butyl ester derived from random-screening hit diphenylacetyl-carbamic acid ethyl ester were designed and synthesized as useful pharmacological tools for the study of the physiological roles mediated by mGlu1 receptors. The synthesis and the structure-activity relationship of this new class of positive allosteric modulators of mGlu1 receptors will be discussed in detail.
